Compare Home Depot Inc (HD) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Home Depot Inc vs Tenet Healthcare Corporation — how do they compare? Home Depot Inc trades at $354.05 (market cap $349.77B), while Tenet Healthcare Corporation trades at $260.39 (market cap $20.93B). The key difference: Home Depot Inc is far larger — about 16.7× Tenet Healthcare Corporation's market cap, and Home Depot Inc pays a 2.66% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| HD | THC | |
|---|---|---|
Market Cap | $349.77B | $20.93B |
Sector | Consumer Cyclical | Health |
52-Week High | $423.42 | $262.63 |
52-Week Low | $297.51 | $161.37 |
Enterprise Value | $411.32B | $32.01B |
Dividend Yield | 2.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Home Depot (HD) trades at $354.48, down 0.32% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $368.75. Recent earnings showed mixed results, with Q1 2026 beating expectations but Q3 2025 missing, while revenue grew to $159.51B in 2025. The stock faces headwinds from weak big-ticket demand and rising mortgage rates, as noted in recent news, but benefits from strong Pro segment growth and housing market tailwinds.
The outlook remains cautiously optimistic, with upside potential from analyst targets and operational resilience, though risks include margin pressure and economic sensitivity. Investors should weigh solid fundamentals against near-term volatility in housing-related spending.
Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.
Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
